Status:
WITHDRAWN
The Effect of Remote Ischemic Preconditioning on Ischemia/Reperfusion Injury in a Liver Transplant Recipient
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Liver Transplant; Complications
Ischemia Reperfusion Injury
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Ischemia and reperfusion injury is unavoidable during a liver transplantation. Remote ischemic preconditioning, a safe and feasible method, has previously been shown to reduce ischemia and reperfusion...
Detailed Description
Background The use of solid organ transplantation, including liver transplantation, is the golden standard for many end-stage solid organ diseases. Ischemia and reperfusion injury is unavoidable durin...
Eligibility Criteria
Inclusion
- Patients undergoing liver transplantation
- Patients aged 18 or above
- Patients who have given an informed consent
Exclusion
- Patients undergoing re-transplantation.
- Patients who do not or cannot give an informed consent.
- Patients who have undergone surgery six weeks prior to liver transplantation.
- Patients with known peripheral vascular disease.
- Patients with an infection localized to the area of rIC-intervention
- Patients with at a high risk or with previous history of multiple thrombo-embolic diseases.
- Patients undergoing active immunosuppressive therapy
Key Trial Info
Start Date :
April 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03758352
Start Date
April 1 2020
End Date
November 1 2022
Last Update
October 8 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.